Sessions Planned

Preliminary Program (subject to change)

Wednesday, April 18

Ancillary Activities:

  • NIH Clinical Center Tour
  • Hill Day training and visits
  • Other Ancillaries
     

Social Event:
Joint ACRT, AFMR, APOR, CR Forum, SCTS Reception

Thursday, April 19

Plenary Session:

  • Patient-Centered Outcome Research
    David Kent, MD, Chair
    Sherine Gabriel, M.D., M.S.c., PCORI Methodology Chair
    John Ioannidis, M.D., D.S.c.
    The Patient-Centered Outcomes Research Institute (PCORI) is a newly established free-standing institute to further human health through outcomes research. Since this activity is an important component of the translational research, a description of scope and focus for PCORI will be presented to the translational research community.
     

Poster Session I

Concurrent Sessions I:

  • FDA and Industry: Designing and Modifying Clinical Trials When the Unexpected Happens
    Abraham Thomas, M.D., Chair
    Speakers: Mary Parks, M.D.; Orville G. Kolterman, MD; Brenda L. Gaydos, PhD
    Traditionally medications for diabetes used the outcome of glucose improvement for the purposes of approval by the FDA. Unexpectedly there was a concern that one of the currently approved diabetes medications may actually increase mortality.  This session will provide information from the FDA and the pharmaceutical industry on how to develop and change guidelines for conducting clinical trials and assessing safety outcomes while studies are currently in progress as well as for the design of future trials.
     
  • Mentoring and Team Building
    Marie Gelato, M.D. Chair
    Speakers: Michael Fleming, M.D.; Ellen Seely, M.D.
    This session will focus on mentoring as it relates to multidisciplinary teams. The speakers will discuss types of mentoring models; what works for some groups and how can mentoring teams be effective. There will be an interactive component that focuses on how to build a mentoring team/network: what are some of the components needed to put a team/network together.
     
  • Changes to the Common Rule/Responsible Conduct of Research
    Nick Steneck, M.D., Chair
    Speakers: Todd Rice – Vanderbilt University; Ethan Cowan – Albert Einstein College of Medicine
    The Department of Health and Human Services is currently re-evaluating the “Common Rule” regulating human research subjects. In this session, three experts will review and comment on how changes in patient informed consent will affect your research studies.
     
  • Adaptive Clinical Trials
    Chair:
    Speakers:
     

Concurrent Sessions II:

  • Serendipitous Science
    Gerald Dorn, M.D., Chair
    Speakers: Arturo Casadevall, M.D., Ph.D.; Stephen Liggett, M.D.; Thomas Cappola M.D., Sc.M.
    The torturous road from mushrooms to melanoma; Bitter taste receptors and asthma; A kidney gene variant that modifies heart failure risk. Louis Pasteur is famously quoted: “Fortune favors the prepared mind.” In this session, you will learn how three successful translational scientists were inspired in unexpected ways to move research from conception to discovery, from discovery to the clinic, and from the clinic to practice.
     
  • The Science of Team Science
    Melissa Begg, M.D., Chair
    Speakers: Fred Meyers, MD; Melissa Begg, MD
    Personal chemistry and expertise are only two components of the critical mixture of the perfect scientific team. This session will share valuable insights in creation, cultivation, and correction to keep the scientific team at top performance.
     
  • The Culture of Data Sharing
    Dan Ford, M.D., MPH, Chair
    The development and complexity of large data sets has resulted in a paradigm shift in the perception of ownership of data. Contemporary researchers must embrace a culture of “data sharing” to meet the demands of regulations, grant conditions, team science collegiality, and community. This session will provide guidelines and case studies that are contributing to the growing culture of data sharing.
     
  • CTSA Administrator Tools
    June Wasser; Maija Neville, Chairs
    Speakers: Elizabeth Wood; Leslie Boone; Michelle Romanick; Barry Coller, MD
    A number of CTSA institutions have created valuable research tools to be shared with the translational science community. This session will identify and describe some of these tools and resources, and develop effective ways to disseminate these tools to the community.
     
  • Mock Study Sections
     

Second Plenary Session:

  • National Center for Advancing Translational Science
    Francis Collins, M.D.
    Dr. Collins, the NIH Director, has overseen biomedical research at the NIH since 2009. Dr. Collins will address the translational science community on his vision for advancing translational science within this new center.
     

Poster Session II

Ancillary Sessions

Friday, April 20

Concurrent Sessions III:

  • Meetings with NIH and AHRQ Program Officers
    A highly valuable opportunity for researchers to meet with NIH Program officers in small groups to discuss grant applications and application strategies.
     
  • Personalized Medicine—Not Just in our Genes
    David Kent, M.D., Chair
    Speakers: John Spertus, Mid America heart Institute, Nilay Shah, Mayo Clinic, Steven Katz, MD, MPH University of Michigan
    The advance of electronic medical records (EMR) will allow enormous advances in clinical research. However, the quantity and detail of information also results in increased risk of loss of privacy. In this session, three outstanding experts will describe both the potential gains and risks of EMR in outcomes research.
     
  • Career Development for Underrepresented Populations
    Jasjit Ahluwalia, M.D., Chair
    Speakers: Priscilla Pemu, MD, MSCR; Jasjit Ahluwalia, MD, MPH, MS
    Ethnic and racial diversity enriches the medical research community, in part by enhancing participation of minority and underserved populations in medical research. A recent NIH study revealed that African-American researchers lag behind others in successfully obtaining R01 funding, the “gold standard” for research career advancement. This session will provide novel approaches to improving career development and mentoring for members of underrepresented populations.
     
  • Team Building: Industry and Business School Perspective
    David Schteingart, M.D., Chair
    Speakers: Phil Phan, Anthony Coyle
    Team building is challenge not unique to translational science. In this session, experts from Industry and Business Schools will describe their secrets for developing effective teamwork.
     

Plenary Session:

  • International Health Research
    Chris Wilson, MD
    Dr. Wilson, Director of the Discovery Program in Global Health for the Gates Foundation will provide an overview of research aiming to prevent, treat and diagnose disease throughout the world.
     

Ancillary Sessions